Priliximab (CEN 000029) is a humanized monoclonal antibody targeting CD4, a surface glycoprotein predominantly expressed on T cells. By binding to CD4, Priliximab induces a significant and sustained decrease in circulating CD4+ T cell populations. This antibody is primarily utilized in the investigation of immune response mechanisms in conditions such as rheumatoid arthritis (RA), providing valuable insights into therapeutic strategies aimed at modulating T cell activity.
Priliximab (CEN 000029) is a humanized monoclonal antibody targeting CD4, a surface glycoprotein predominantly expressed on T cells. By binding to CD4, Priliximab induces a significant and sustained decrease in circulating CD4+ T cell populations. This antibody is primarily utilized in the investigation of immune response mechanisms in conditions such as rheumatoid arthritis (RA), providing valuable insights into therapeutic strategies aimed at modulating T cell activity.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
